Translating pharmacology models effectively to predict therapeutic benefit-Reference-Cited by-同舟云学术

Translating pharmacology models effectively to predict therapeutic benefit

Published:2022-06 Issue:6 Volume:27 Page:1604-1621
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Dudal Sherri,Bissantz Caterina,Caruso Antonello,David-Pierson Pascale,Driessen Wouter,Koller Erich,Krippendorff Ben-Fillippo,Lechmann Martin,Olivares-Morales Andrés,Paehler Axel,Rynn Caroline,Türck Dietrich,Van De Vyver Arthur,Wang Ken,Winther Lotte

Funder

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference127 articles.

1. Trial watch: Phase II failures: 2008–2010;Arrowsmith;Nat Rev Drug Discov,2011

2. Trial watch: phase III and submission failures: 2007–2010;Arrowsmith;Nat Rev Drug Discov,2011

4. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction;Oddo;Neuron,2003

5. Development of translational pharmacokinetic-pharmacodynamic models;Mager;Clin Pharmacol Ther,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges;Clinical Pharmacokinetics;2024-06-18

2. The estimation and translation uncertainties in applying NOAEL to clinical dose escalation;Clinical and Translational Science;2024-05-29

3. Drug discovery processes: When and where the rubber meets the road;Managing the Drug Discovery Process;2023

4. Supplemental treatment to atropine improves the efficacy to reverse nerve agent induced bronchoconstriction;Chemico-Biological Interactions;2022-09